The Global Halometasone Market was valued at USD 76.2 Million in 2025 and is projected to reach USD 108.9 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period (2024–2034). This growth is primarily driven by the rising global prevalence of inflammatory skin conditions like eczema and psoriasis, increased healthcare expenditure in emerging economies, and the strong efficacy profile of Halometasone as a potent topical corticosteroid.

As the demand for effective dermatological treatments continues to surge, the focus shifts to the key pharmaceutical manufacturers who are ensuring the supply, quality, and advancement of therapeutic solutions. In this blog, we profile the Top 10 Companies in the Halometasone Market—a group of established pharmaceutical players and specialized manufacturers shaping the landscape of topical corticosteroid therapies.

Download FREE Sample Report:
Halometasone Market – View in Detailed Research Report

---

🔟 1. Chongqing Huabang Shengkai Pharmaceutical Co., Ltd.

Headquarters: Chongqing, China
Key Offering: Halometasone Active Pharmaceutical Ingredient (API), Finished Dosage Forms

Chongqing Huabang Shengkai Pharmaceutical is a prominent manufacturer of pharmaceutical ingredients, with a significant focus on corticosteroid APIs. The company has established itself as a key supplier in the Halometasone supply chain, adhering to stringent Good Manufacturing Practice (GMP) standards to ensure product purity and consistency for global markets.

Strategic Initiatives:

• Investment in advanced synthesis and purification technologies for high-purity Halometasone (>99%)

• Expansion of production capacity to meet growing international demand

• Strategic partnerships with formulation companies for finished product development

---

9️⃣ 2. Tianjin Pharmaceutical Group Co., Ltd. (TPG)

Headquarters: Tianjin, China
Key Offering: Halometasone Monohydrate, Pharmaceutical Intermediates

Tianjin Pharmaceutical Group is one of China’s largest and oldest pharmaceutical enterprises, with a diverse portfolio that includes steroid hormones. The company leverages its extensive R&D capabilities and integrated manufacturing platform to produce high-quality Halometasone, serving both domestic and international pharmaceutical clients.

Strategic Initiatives:

• Continuous process optimization for cost-effective and scalable Halometasone production

• Focus on regulatory compliance for exports to regulated markets like Europe and Southeast Asia

---

8️⃣ 3. Hunan Mingrui Pharmaceutical Co., Ltd.

Headquarters: Hunan, China
Key Offering: Halometasone API, Custom Synthesis Services

Hunan Mingrui Pharmaceutical specializes in the research, development, and production of steroid APIs. The company has carved a niche in the Halometasone market through its technical expertise in steroid chemistry and its commitment to quality control, making it a reliable partner for generic drug manufacturers worldwide.

Strategic Initiatives:

• Development of proprietary synthesis routes to enhance yield and purity

• Active pursuit of certifications from international regulatory bodies

---

7️⃣ 4. Schering-Plough (Merck & Co.)

Headquarters: Kenilworth, New Jersey, USA (Global Operations)
Key Offering:Sicorten® (Branded Halometasone Cream/Ointment)

Originally developed by Schering-Plough, which is now part of Merck & Co., Sicorten is one of the most well-known branded formulations of Halometasone. This product is widely prescribed for its potency in treating severe dermatitis and psoriasis, and it continues to be a key product in the dermatology portfolios of Merck in various regions.

Strategic Initiatives:

• Ongoing post-marketing surveillance and clinical studies to reinforce the safety profile of Sicorten

• Strategic marketing and distribution partnerships to maintain brand presence in key markets

Download FREE Sample Report:
Halometasone Market – View in Detailed Research Report

---

6️⃣ 5. Glenmark Pharmaceuticals Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Generic Halometasone Cream (e.g., Halovate®)

Glenmark is a global pharmaceutical company with a strong presence in dermatology. The company markets a branded generic version of Halometasone, which is a leading product in its dermatological portfolio. Glenmark’s extensive distribution network ensures wide availability of its Halometasone cream across Asia, Africa, and Latin America.

Strategic Initiatives:

• Portfolio expansion in dermatology with a focus on branded generics

• Investment in sales force training to promote dermatological products to healthcare professionals

---

5️⃣ 6. Intas Pharmaceuticals Ltd.

Headquarters: Ahmedabad, Gujarat, India
Key Offering: Halometasone Topical Formulations

Intas Pharmaceuticals is a leading, vertically integrated pharmaceutical company known for its robust product portfolio in chronic therapeutic areas, including dermatology. The company manufactures and markets Halometasone formulations, leveraging its strong manufacturing capabilities and widespread regulatory approvals.

Strategic Initiatives:

• Focus on backward integration to control API supply and ensure cost competitiveness

• Aggressive market penetration strategies in emerging economies

---

4️⃣ 7. Moehs Iberica, S.L. (Part of CordenPharma)

Headquarters: Barcelona, Spain
Key Offering: High-Potency Corticosteroid APIs, including Halometasone

Moehs Iberica, a member of the CordenPharma Group, is a Contract Development and Manufacturing Organization (CDMO) specializing in complex molecules, including steroids. The company is a key European supplier of Halometasone API, serving pharmaceutical companies that require high-quality ingredients for their topical formulations.

Strategic Initiatives:

• Investment in cGMP-compliant manufacturing facilities for highly potent active pharmaceutical ingredients (HPAPIs)

• Providing end-to-end services from API development to regulatory support

---

3️⃣ 8. Cipla Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Halometasone Cream under various brand names

Cipla is a global pharmaceutical giant with a deep commitment to affordable medicine. The company offers Halometasone in its dermatology range, ensuring access to this effective treatment across multiple price-sensitive markets. Cipla’s strong brand equity and vast distribution network make it a significant player.

Strategic Initiatives:

• Emphasis on accessibility and affordability in emerging markets

• Digital marketing initiatives to reach dermatologists and patients effectively

---

2️⃣ 9. LGM Pharma

Headquarters: Boca Raton, Florida, USA
Key Offering: Halometasone API for Pharmaceutical Distribution

LGM Pharma is a leading global API supplier and distributor. While not a primary manufacturer, LGM plays a crucial role in the Halometasone market by providing a reliable supply chain link between API manufacturers and pharmaceutical companies in North America and other regions, ensuring regulatory and quality compliance.

Strategic Initiatives:

• Maintaining a diversified supplier base to mitigate supply chain risks

• Providing comprehensive documentation and regulatory support to clients

---

1️⃣ 10. Avik Pharmaceutical

Headquarters: Hyderabad, Telangana, India
Key Offering: Halometasone API and Formulations

Avik Pharmaceutical is a specialized company focused on manufacturing steroid and hormone APIs and formulations. It has emerged as a competitive player in the Halometasone space, offering quality products at competitive prices, primarily catering to the growing demand in Asian and African markets.

Strategic Initiatives:

• Expansion of manufacturing capabilities for topical dosage forms

• Focus on building a strong B2B presence in specific geographic niches

Get Full Report Here:
Halometasone Market – View in Detailed Research Report

---

🧴 Outlook: The Future of Halometasone Relies on Innovation and Accessibility

The Halometasone market is characterized by steady growth, underpinned by its established efficacy. However, the future trajectory will be shaped by factors beyond simple API production.

📈 Key Trends Shaping the Market:

• Shift towards Combination Therapies: Development of Halometasone combined with antifungals or antibiotics to treat complex skin infections.

• Growing Importance of Pharmacovigilance: Increased focus on the long-term safety monitoring of potent topical corticosteroids.

• Expansion in Emerging Markets: Rising disposable income and improving healthcare infrastructure in Asia-Pacific and Latin America driving market growth.

• Regulatory Harmonization: Stricter regulatory standards pushing manufacturers to invest in quality and compliance for global market access.

Get Full Report Here:
Halometasone Market – View in Detailed Research Report

The companies listed above are not only supplying a critical therapeutic agent—they are integral to the global ecosystem of dermatological care, ensuring that patients suffering from debilitating skin conditions have access to effective treatment options.